News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu"



4/11/2014 6:30:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Researchers who have fought for years to get full data on Roche's flu medicine Tamiflu said on Thursday that governments who stockpile it are wasting billions of dollars on a drug whose effectiveness is in doubt.

In a review of trial data on Tamiflu, and on GlaxoSmithKline's flu drug Relenza, scientists from the respected research network the Cochrane Review said that while the medicines can shorten flu symptoms by around half a day, there is no good evidence behind claims they cut hospital admissions or lessen complications of the disease.

Help employers find you! Check out all the jobs and post your resume.

Read at Fox News
Read at Time
Read at Reuters
Read at Forbes
Read at Wall Street Journal


comments powered by Disqus
Roche
 
 
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES